Transfections in the presence of chloroquine and pH tracking studies suggest that a contributing factor to the success of the caveolar pathway is avoidance of lysosomes. Collectively, these data demonstrate that uptake mechanism and subsequent endocytic processing are important design parameters for gene delivery materials.
INTRODUCTION
The most effective gene delivery strategy for a given application is often dictated by particular disease characteristics. For systemic diseases like hemophilia, treating any of a number of tissues or cell types may be adequate provided that sufficient levels of the transgene product are expressed and have access to the circulatory system. 1 However, for localized disorders like cancer or cystic fibrosis, it is often beneficial and sometimes critical to target gene delivery vectors to specific diseased cell types. 2, 3 It has been reported that the "receptors" for polycationic gene delivery vectors are clusters of negatively charged proteoglycans on the cell surface. Unfortunately, these "receptors" do not afford cell specificity. 4 To direct gene delivery vehicles to particular cells, peptides, proteins or small molecule ligands may be attached to the surface of polyplexes. [5] [6] [7] [8] Ideally, the ligand chosen would target a receptor found on only one particular type of diseased cell, thereby ensuring that healthy cells are unaffected. While such targeting methods have met with success in generating particles that are capable of specific cellular interactions, little attention has been given to the possible effects on the intracellular trafficking of targeted gene delivery complexes.
Transferrin and folic acid are commonly used ligands for drug and gene targeting due to the overexpression of their respective receptors on many cancer cells. [9] [10] [11] Notably, these ligands utilize different uptake mechanisms which ultimately result in distinct intracellular processing.
Transferrin is internalized by clathrin-coated pits and follows the traditional endolysosomal pathway. 12 More specifically, upon ligand binding, clathrin is recruited to receptor sites, forming a cage-like structure that stabilizes the vesicle as it buds from the membrane. As the endocytic 4 vesicle moves through the cell, proton pumps anchored within its membrane gradually acidify the vesicle contents from approximately pH 7.2 to pH 6. At this pH, the vesicle is termed an early endosome. Through continued acidification, the early endosome eventually reaches pH 5
at which point it is considered a late endosome. Finally, when the endosome has fully matured, it fuses with lysosomes and reaches a pH as low as 4.5 where degradative enzymes are activated.
Folic acid, in contrast, is internalized by caveolae-flask-like invaginations on the cell surface that bud from membrane microdomains rich in cholesterol and the protein caveolin. 13 Upon receptor/ligand binding, the cell membrane pinches off to form a vesicle that is directed towards caveosomes. Endocytosis through caveolae and the fate of caveosomes are less well understood than its clathrin-mediated counterpart. There is speculation that caveosomes may fuse with early endosomes through the action of the GTPase Rab5 or proceed through the cell by an independent path. 14 Unlike the clathrin pathway, however, caveosomes avoid trafficking to lysosomes. In the case of the cholera toxin binding subunit (CTxB), one of the better studied ligands utilizing caveolar uptake, the ligand is believed to be transported to the Golgi complex via early endosomes. 15, 16 Simian virus 40 (SV40), which also utilizes caveolar uptake, is thought to avoid the harsh pH and enzymatic environment of the endosomal-lysosomal pathway and remain entirely in pH-neutral caveosomes at it travels through the cell. 17, 18 Polyethylenimine (PEI) is an efficient off-the-shelf gene delivery material. It is believed that the relatively high gene delivery efficiency of PEI is attributable to its ability to act as a proton sponge. 19 According to the proton sponge hypothesis, these polyplexes are sequestered in endocytic vesicles that are acidified by V-type ATPases within the endosomal membrane. PEI, 5 with its abundance of primary, secondary and tertiary amines, is thought to effectively buffer the vesicle lumen. As increasing numbers of protons and counter ions are pumped in to acidify the buffered compartment, water is osmotically driven into the lumen. The excess water is believed to cause swelling and eventual lysis of the endosome, releasing polyplexes into the cytosol. This proposed mechanism for the endosomal escape of proton sponge-containing polyplexes has been met with both corroborating and conflicting data. [20] [21] [22] [23] Recently, we demonstrated that acetylation of PEI resulting in decreased buffering capacity-as well as weaker interactions with nucleic acids-significantly improved gene delivery efficiency, suggesting that the proton-sponge effect may not be a complete representation of the intracellular processing of such polyplexes. 24, 25 The study presented here examines the importance of the caveolar uptake pathway that potentially avoids vesicle acidification and thus precludes the proton sponge effect, compared to the clathrin-mediated uptake pathway that is inherently tied with endosome acidification, on PEImediated transfection of HeLa cells. albeit only at the sub-optimal polymer:DNA weight ratio of 0.5:1 (p < 0.1, Figure 1a) . This is likely due to non-specific electrostatic interactions between the negatively charged cell 6 membrane and positively charged polyplexes at higher weight ratios. For subsequent experiments, transfections were performed with complexes formed at the polymer:DNA weight ratio of 0.5:1 using PEI-Fol(1.1). The uptake of targeted and non-targeted polyplexes was similar at times up to one hour post-transfection. Corresponding with the increased transfection efficiency, PEI-Fol(1.1)/DNA polyplexes showed a 1.5-fold increase in uptake in HeLa cells relative to unmodified PEI polyplexes at two and four hours post-transfection. (p < 0.05, Figure   1b ). The delayed uptake of PEI-Fol(1.1)/DNA complexes is likely due to the slow kinetics of caveolae-mediated uptake. 9, 26, 27 . To verify that folate-targeted complexes entered cells through folate receptors, a competitive inhibition assay was performed. Addition of 100 to 300 μM free folic acid to the transfection medium reduced PEI-Fol(1.1)/DNA-mediated luciferase expression by roughly four-fold relative to folate-free conditions (p < 0.05, Figure 1c ). Free folic acid also reduced the uptake of PEI-Fol(1.1)/DNA by 25% relative to uptake in the absence of folic acid (p < 0.05, Figure 1d) . Combined, the data indicate that at least a portion of the folate-targeted complexes entered cells via the folate receptor.
RESULTS

Generation of folate-targeted PEI
Generation of transferrin-targeted PEI
HeLa cells were transfected with transferrin-targeted PEI complexes formed at a total polymer:DNA weight ratio of 0.5:1, based on the results described above, to limit non-specific electrostatic interactions with cell membrane components. Following the procedure of Kircheis et al., the complexes were formed with varying ratios of unmodified PEI to transferrin-targeted PEI. 8 Polyplexes composed of between 10% and 50% PEI-Tf yielded gene expression levels between two-and eight-fold higher than unmodified PEI (p < 0.05, 
Uptake following selective endocytic inhibition with small molecule drugs
Various drugs are capable of selectively inhibiting either clathrin-or caveolae-mediated endocytosis. The drug chlorpromazine inhibits clathrin-mediated uptake by disassociating the clathrin-coated pits that form at ligand binding sites. 30 Amantadine prevents clathrin-mediated uptake by blocking the budding of clathrin-coated vesicles into the cell. 31 Caveolae are known to bud from microdomains on the cell surface that are rich in cholesterol. The drug methyl-β-cyclodextrin (mβCD) inhibits caveolar uptake by sequestering cholesterol on the cell surface. 32 Genistein, a tyrosine kinase inhibitor, blocks caveolar uptake by preventing the phosphorylation of caveolin, a scaffolding protein that is the main component of caveolae. 33 Drug concentrations were chosen based on relevant literature and the ability of the drug to prevent the uptake of 150-nm fluorescent polystyrene nanoparticles conjugated to either folate or transferrin (data not shown). To test the effect of the inhibitor drugs on the uptake of folate-and transferrin-targeted PEI, polyplexes were labeled with the fluorescent DNA intercalator YOYO-1 and used to transfect cells that were subsequently subjected to flow cytometry (Figure 4a) . It is evident that uptake was not completely inhibited by any of the drugs at the concentrations tested. However, the effects were more pronounced in certain targeted species than in others. Uptake of folatetargeted polyplexes was more substantially inhibited in the presence of genistein and mβCD than 9 chlorpromazine and amantadine as compared to PEI-Fol(1.1)/DNA uptake in the absence of drugs (p < 0.05). Correspondingly, uptake of transferrin-targeted polyplexes was inhibited to a greater extent by chlorpromazine and amantadine than genistein and mβCD relative to PEITf(25%)/DNA uptake in the absence of drugs (p < 0.05). Unmodified PEI/DNA uptake was reduced by both caveolae and clathrin inhibitors as compared to drug free conditions, indicating that it likely enters cells through a combination of both pathways (p < 0.05). The non-specific effect of the drugs on the uptake of targeted complexes is likely a combination of their cytotoxicity (data not shown) as well as the potential for non-specific uptake of targeted complexes. Nonetheless, the data suggest that the folate-and transferrin-targeted complexes are predominantly endocytosed by caveolae-and clathrin-mediated processes, respectively.
Transfection following selective endocytic inhibition with small molecule drugs
When unmodified as well as folate-and transferrin-targeted polyplexes were used to transfect 
Transfection in the presence of chloroquine and bafilomycin A1
A major distinction between clathrin and caveolae-mediated endocytosis is trafficking to lysosomes. Ligands entering the cell via the clathrin pathway are believed to ultimately enter lysosomes while ligands entering the cell via a caveolar pathway do not. To investigate whether avoidance of lysosomes in the caveolar pathway is a component in successful gene delivery, transfections were performed in the presence of the lysosomotropic drug chloroquine. When chloroquine is added to cells at 20 μM in the external medium, its intracellular concentration reaches 5 mM. 34 The localized concentration within lysosomes is likely even higher. Because of its aromatic ring structure, chloroquine is able to intercalate DNA, thereby causing a conformational change that is capable of inhibiting enzymatic DNA degradation. 35, 36 The addition of 5 mM chloroquine prevents total DNA digestion, as evidenced by the faint pGL3
band seen in the corresponding lane (Figure 6a) . The degradation inhibition is more effective at higher chloroquine concentrations, resulting in brighter, more pronounced bands.
Typically, chloroquine is used as an endosomal buffering agent with gene delivery vectors that lack the ability to buffer endosomes, such as polylysine. Since PEI is an innate buffering agent, the effect of chloroquine in cells can be attributed to its ability to prevent lysosomal DNA type ATPases affected by baflilomycin A1. 38 Thus, the inhibitory effect of bafilomycin A1 may be due to its ability to prevent endosome acidification outside of the clathrin pathway, or bafilomycin A1 may interfere with the caveolar pathway in currently unknown ways.
Polyplex pH measurement by ratiometric flow cytometry.
To further explore the trafficking of polyplexes to lysosome-like pH environments, ratiometric flow cytometry was performed to measure the average pH surrounding targeted and untargeted gene delivery complexes. 20 The 
DISCUSSION
Practical gene delivery vectors will likely utilize some form of cell-specific targeting. Because of this, it is important that studies of the intracellular behavior of gene delivery vectors include the effects of cell targeting and associated endocytic trafficking. Recent work has highlighted the importance of caveolar uptake and processing over the clathrin pathway in successful gene delivery in multiple cell types. 27, 39, 40 To this end, the work presented here addresses the differences in processing of PEI gene delivery complexes targeted to clathrin and caveolar pathways using transferrin and folate, respectively.
The ability of caveolae inhibitor drugs (Figure 4b ) and siRNA-mediated caveolin- To understand the deficiencies in the clathrin pathway-and thus the important intracellular steps in successful gene delivery-it is useful to compare the differences in cellular processing of ligands within the two pathways. With regard to polyplex gene delivery, the most important difference between the two routes is trafficking to lysosomes. Thus, it seems likely that a portion of the efficiency of complexes internalized via the caveolar pathway is avoidance of lysosomes and degradation therein.
At elevated concentrations chloroquine is able to prevent the enzymatic degradation of plasmid DNA by affecting a conformational change in DNA that is believed to prohibit the binding of DNAse. As a lysosomotropic agent, chloroquine accumulates preferentially in lysosomes. Thus, its ability to inhibit DNAse digestion is limited to DNA that has entered lysosomes. In the context of the work presented here, chloroquine improved the gene delivery efficiency of only transferrin-targeted polyplexes (Figure 6b ). This suggests that lysosomal trafficking is an important barrier for complexes entering the cell through the clathrin pathway. The beneficial effects of chloroquine on PEI-Tf(25%)/DNA transfection could be elminated by preventing chloroquine accumulation in lysosomes through the use of bafilomycin A1. However, bafilomycin A1 alone reduced the gene delivery efficiency of not only transferrin-targeted polyplexes, but also unmodified and folate-targeted polyplexes. This reduction in efficiency has been interpreted to suggest that endosome acidification is an essential step in successful gene delivery. 41 However, Mineo et al. have shown that caveolin-1 colocalizes with the same V-type ATPases inhibited by bafilomycin A1. 38 Thus, the reduction in gene delivery by bafilomycin A1 may be due to effects outside of its ability to prevent endosome acidification during clathrinmediated uptake-bafilomycin might also interfere with the caveolar pathway.
Measurement of the pH environment of PEI-based gene delivery complexes suggests that all three types of polyplexes, regardless of caveolar-or clathrin-mediated internalization, are exposed to the acidic environments of early endosomes during the first four hours posttransfection. Based on the significant decrease in transgene expression in the presence of bafilomycin A1 (Figure 6b) , this acidification appears to be an essential step in efficient gene delivery. Evidence suggests that some caveolar vesicles fuse with early endosomes for sorting during their movement through the cell. 14, 42 The acidic conditions surrounding folate-targeted complexes (Figure 7) support the fusion hypothesis. After four hours post-transfection, the differences between folate-targeted, transferrin-targeted and untargeted polyplexes became evident. From four to eight hours, folate-targeted complexes remained at near constant pH (pH 5.5) while transferrin-targeted and untargeted complexes continued to be acidified. Early endosomes typically exhibit a pH of 6.0. Keeping in mind that the ratiometric assay employed measures the average pH of all polyplexes within the cells, it is likely that some complexes reside within environments at a higher or lower pH than recorded. Thus, it is conceivable that during four to eight hours post-transfection a portion of the folate-targeted complexes could be found sequestered in early endosomes while others had moved into more acidic environments.
With their lower and steadily decreasing pH from four to eight hours, it appears that the transferrin-targeted and untargeted complexes were localized in late endosomes en route to lysosomes. Localization of untargeted PEI/DNA in higher pH environments than transferrintargeted polyplexes suggests that a smaller fraction of the untargeted complexes were present in the pathway from the endosomes to lysosomes. This supports the previous data suggesting that untargeted complexes enter through a non-specific combination of both caveolar and clathrin pathways. At twelve hours post-transfection, the pH 4.7 environment surrounding transferrintargeted and untargeted complexes suggests that they had entered lysosomes. At the same time, the bulk of folate-targeted complexes appeared to be entering the late endosome at pH 5.0. At twenty hours post-transfection, the folate-targeted complexes joined the transferrin-targeted and untargeted complexes in lysosomes. Thus, while folate-targeted complexes did not completely bypass acidic environments, they appeared to spend a greater amount of time in early endosomes and were ultimately trafficked to lysosomes at a slower rate than either transferrin-targeted or untargeted complexes.
In summary, cell targeting can influence the intracellular processing of PEI-containing gene delivery vehicles. The results presented here suggest that complexes targeted to the caveolar pathway result in efficient gene delivery in HeLa cells while those targeted to the clathrin pathway do not. While both endocytic routes involve acidification in the early endosomes, the caveolar pathway avoids rapid and direct trafficking to the more acidic late endosomes and lysosomes, suggesting that this lysosomal trafficking is a source of inefficiency with the clathrin pathway. 
MATERIALS AND METHODS
Materials
Cells and plasmids
The HeLa human cervical carcinoma cell line used in this study was a gift from Dr. Sandra
McMasters (University of Illinois, Urbana, IL). The cells were cultured according to their ATCC protocols at 37 °C and 5% CO 2 in Dulbecco's modified Eagle's medium. The growth medium was supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin. The 5.3-kilobase expression vector pGL3 (Promega, Madison, WI) coding for the luciferase gene driven by the SV40 promoter and enhancer, was grown in DH5α E. coli (Gibco BRL, Rockville, MD) and purified with a commercial plasmid purification kit (Bio-Rad, Hercules, CA).
Generation of folate-targeted PEI
Folic acid was conjugated to PEI according to the procedure of Guo et al. 43 Briefly, folic acid was dissolved in dimethylsulfoxide with a 1.1 molar excess of both N-hydroxysuccinimide (NHS) and N,N'-Dicyclohexylcarbodiimide (DCC). The reaction was allowed to stir overnight at room temperature. The following day, the insoluble dicyclohexylurea byproduct was removed by filtration. The NHS-folate product was collected, quantified by ultraviolet absorption at 363 nm and stored at 4 °C until needed. NHS-activated folate was conjugated to the primary amines of 25-kDa branched PEI by dissolving both in 0.1 M sodium bicarbonate buffer (pH 8.3) at the desired labeling ratio and stirring overnight at room temperature. The PEI-folate product was purified from reactants by gel filtration chromatography (PD-10, GE Healthcare, Uppsala, 20 Sweden) and characterized using a ninhydrin assay (PEI quantification) and ultraviolet absorption at 363 nm (folate quantification).
Generation of transferrin-targeted PEI
Human apo-transferrin was conjugated to PEI using the heterobifunctional crosslinker sulfo-KMUS. Briefly, 25-kDa branched PEI was first thiolated with 2-iminothiolane in PBS containing 5 mM EDTA and purified by gel filtration chromatography (PD-10, GE Healthcare, Uppsala, Sweden). The presence of thiol groups was quantified with Ellman's reagent. Sulfo-KMUS was reacted separately with the primary amines of human apo-transferrin and purified by gel filtration chromatography (PD-10, GE Healthcare, Uppsala, Sweden) to generate a thiolreactive form of the protein. The thiol-reactive transferrin and thiolated PEI were then combined at a 1:1 molar ratio in PBS containing 5 mM EDTA and allowed to react overnight at 4 °C. The resulting PEI-transferrin conjugate was purified from reactants using a 100,000 MWCO centrifugal filter (Millipore, Temecula, CA). The concentration of PEI in the retentate was quantified using a ninhydrin assay. Transferrin covalently linked to PEI was quantified using a BCA protein assay. Prior to transfection, the apo-transferrin was loaded with iron by adding two molar equivalents of ferric citrate to the PEI-transferrin conjugate and used without further purification.
Polyplex preparation and transfection
Cells were plated in 24-well tissue culture plates at 5 × 10 4 cells/well 24 h prior to transfection.
DNA/polymer complexes were prepared at room temperature by dissolving 4 µg of DNA in approximately 100 μl of Mili-Q water and adding an equal volume of polymer solution to 21 achieve the desired polymer:DNA weight ratio. Complexes were then incubated at room temperature for 20 min. For transfections performed in the presence of caveolae inhibitors (50 μg/ml genistein, 10 mg/ml methyl-β-cyclodextrin) or clathrin inhibitors (5 μg/ml chlorpromazine, 1 mM amantadine), the growth medium was replaced with folate-free, serumfree medium containing the desired drug one hour prior to transfection. For transfections in the presence of 20 μM chloroquine, 10 nM bafilomycin A1 or both, the growth medium was replaced with folate-free, serum-free medium containing the desired drug immediately prior to transfection. If no drugs were present, the medium was also replaced with folate-free, serumfree medium immediately prior to transfection. At the time of transfection, 50 µl of polyplex solution was added to each well (1 µg plasmid/well). The transfection medium was replaced with serum-supplemented growth medium 2 h post-transfection. Luciferase expression was quantified 24 h post-transfection using the Promega luciferase assay system (Promega, Madison, WI). Luciferase activity was measured in relative light units (RLU) using a Lumat LB 9507 luminometer (Berthold, GmbH, Germany) and normalized to total cell protein using a BCA protein assay kit.
Down-regulation of caveolin-1 and clathrin heavy chain expression
Cells were plated in 6-well tissue culture plates at 1 × 10 5 cells/well 24 h prior to treatment. clathrin heavy chain primary antibodies were used at a 1:500 dilution.
Flow cytometry
To prepare flow cytometry samples, DNA complexes were formed with either targeted or 
Competitive inhibition of uptake and transfection
Unlabeled and YOYO-1 labeled DNA/polymer complexes were prepared as described previously. Thirty minutes prior to transfection, the growth medium on the HeLa cells was replaced with folate-free, serum-free medium containing the desired concentrations of either free folic acid or iron-loaded transferrin and incubated at 4 °C. At the time of transfection, 50 μl of the polyplex solution was added to each well and the cells were moved to 37 °C. The transfection medium was replaced with serum-supplemented growth medium 30 minutes posttransfection. The cells were then subjected to either flow cytometry or allowed to grow for 24 h prior to lysis and reporter gene measurement.
Investigation of colocalization
The primary amines of unmodified or targeted PEI samples were reacted with NHS-ester or PEI-Tf(25%) polyplexes (green) and immunostained for early endosome marker EEA-1 or
